
Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …

GlaxoSmithKline could be fined £2.6 billion after the Office of Fair Trading (OFT) alleged it paid generics firms to slow …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

